Swiss National Bank Grows Stock Position in Patterson Companies, Inc. (NASDAQ:PDCO)

Swiss National Bank raised its holdings in Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 6.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 164,700 shares of the company's stock after buying an additional 10,400 shares during the quarter. Swiss National Bank owned about 0.19% of Patterson Companies worth $5,083,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in PDCO. Values First Advisors Inc. lifted its holdings in Patterson Companies by 2.9% in the fourth quarter. Values First Advisors Inc. now owns 11,961 shares of the company's stock worth $369,000 after buying an additional 337 shares during the period. Anchor Investment Management LLC lifted its stake in shares of Patterson Companies by 20.5% in the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock valued at $51,000 after purchasing an additional 400 shares during the period. Blue Trust Inc. boosted its position in shares of Patterson Companies by 18.0% during the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock valued at $84,000 after purchasing an additional 417 shares in the last quarter. Spire Wealth Management grew its stake in Patterson Companies by 11.2% in the fourth quarter. Spire Wealth Management now owns 4,160 shares of the company's stock worth $128,000 after purchasing an additional 419 shares during the period. Finally, US Bancorp DE grew its stake in Patterson Companies by 1.6% in the fourth quarter. US Bancorp DE now owns 32,767 shares of the company's stock worth $1,011,000 after purchasing an additional 514 shares during the period. 85.43% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Patterson Companies Stock Performance

PDCO traded down $0.04 during midday trading on Friday, hitting $31.21. 837,579 shares of the company traded hands, compared to its average volume of 1,054,981. Patterson Companies, Inc. has a 52 week low of $19.45 and a 52 week high of $31.79. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. The company's 50-day moving average is $31.07 and its 200 day moving average is $26.44. The firm has a market capitalization of $2.76 billion, a PE ratio of 18.25, a price-to-earnings-growth ratio of 2.71 and a beta of 0.99.

Analyst Ratings Changes

A number of analysts have recently commented on PDCO shares. Mizuho started coverage on shares of Patterson Companies in a report on Wednesday, December 4th. They set a "neutral" rating and a $23.00 target price on the stock. Morgan Stanley upped their price target on Patterson Companies from $27.00 to $31.35 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Leerink Partnrs cut Patterson Companies from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 11th. StockNews.com started coverage on Patterson Companies in a research note on Thursday. They issued a "hold" rating on the stock. Finally, Piper Sandler lowered their price target on Patterson Companies from $26.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, December 6th. Eleven research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Patterson Companies has an average rating of "Hold" and a consensus price target of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.